ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,033Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 2456

$753K Total Retail Price of All Prescriptions

Rank: 88 out of 2456

380 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,192 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,057 1,054 1 9
TRAZODONE HCL 678 576 2 17
LEVOTHYROXINE SODIUM 535 429 3 4
SIMVASTATIN 403 342 4 2
FUROSEMIDE 394 360 5 8
LISINOPRIL 336 318 6 1
CITALOPRAM HBR 329 328 7 14
METOPROLOL TARTRATE 322 289 8 10
AMLODIPINE BESYLATE 312 287 9 5
MIRTAZAPINE 310 293 10 29
GABAPENTIN 302 217 11 16
DONEPEZIL HCL 284 284 12 23
OMEPRAZOLE 280 231 13 3
SERTRALINE HCL 230 196 14 21
ATENOLOL 225 214 15 6
POTASSIUM CHLORIDE 220 191 16 33
DIVALPROEX SODIUM 205 175 17 51
METFORMIN HCL 204 187 18 11
NAMENDA 197 191 19 42
QUETIAPINE FUMARATE 178 163 20 47
OLANZAPINE 176 167 21 57
RISPERIDONE 155 110 22 50
METOPROLOL SUCCINATE 139 135 23 13
PREDNISONE 134 106 24 39
TAMSULOSIN HCL 129 116 25 32
ATORVASTATIN CALCIUM 125 112 26 12
LANTUS 118 85 27 44
CYMBALTA 108 96 28 65
POLYETHYLENE GLYCOL 3350 99 70 29 64
ABILIFY 98 76 30 95
TRAMADOL HCL 95 81 31 24
ALLOPURINOL 93 80 32 27
PAROXETINE HCL 90 74 33 56
NYSTATIN 88 68 34 99
OXYCODONE HCL 86 60 S2 35 38
HYDROCODONE-ACETAMINOPHEN 85 84 S3 36 20
ADVAIR DISKUS 80 70 37 36
HYDROCHLOROTHIAZIDE 75 63 38 7
PANTOPRAZOLE SODIUM 73 71 39 37
LEVETIRACETAM 72 54 40 90
LIDODERM 71 67 41 58
SEROQUEL 66 65 42 102
CLOPIDOGREL 66 60 42 55
FLUOXETINE HCL 65 44 44 45
MORPHINE SULFATE 65 35 S2 44 226
ISOSORBIDE MONONITRATE ER 63 54 46 48
COLCRYS 63 62 46 171
SPIRIVA 63 59 46 43
GLIPIZIDE 61 61 49 46
IBUPROFEN 60 44 50 52
NITROFURANTOIN MONO-MACRO 58 55 51 231
LEVOFLOXACIN 57 53 52 103
FLUTICASONE PROPIONATE 56 40 53 30
ALENDRONATE SODIUM 55 54 54 19
CLOZAPINE 54 54 55 75
AZITHROMYCIN 52 47 56 60
NOVOLOG 51 33 57 100
RANITIDINE HCL 51 40 57 31
FINASTERIDE 50 50 59 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.